Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

Completed · Not applicable

Conditions studied: Atrial Fibrillation, Hypertension

In brief

The purpose of this clinical study is to evaluate the feasibility of performing both renal nerve denervation and pulmonary vein isolation on the same patient with the intent of characterizing both safety and effectiveness in a paroxysmal and persistent atrial fibrillation population with hypertension. To assess safety, the study will measure the occurrence of a composite safety endpoint and, to assess effectiveness, the study will measure freedom of chronic treatment failure through a minimum of six months of follow-up.

Key facts

Study ID

NCT02064764

Run by

Medtronic Vascular

People needed

102

Starts

2015-02-01

Expected to finish

2021-04-19

Last updated by the study team

2024-02-23

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mercy Medical Group-Cardiology — Sacramento, California, United States
• Lahey Hospital and Medical Center — Burlington, Massachusetts, United States
• UPHS-Marquette — Marquette, Michigan, United States
• NYU Langone Medical Center — New York, New York, United States
• The Ohio State University — Columbus, Ohio, United States
• Doylestown Hospital — Doylestown, Pennsylvania, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• Virginia Mason Medical Center — Seattle, Washington, United States
• Swedish Medical Center Cherry Hill — Seattle, Washington, United States
• Universitätsklinikum des Saarlandes — Homburg, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.